These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown? Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hrušková Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesař V, Wetzels J, Willcocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A, RITERM study group. Autoimmun Rev; 2020 Nov; 19(11):102671. PubMed ID: 32942039 [Abstract] [Full Text] [Related]
28. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases. Kronbichler A, König P, Busch M, Wolf G, Mayer G, Rudnicki M. Wien Klin Wochenschr; 2013 Jun; 125(11-12):328-33. PubMed ID: 23624956 [Abstract] [Full Text] [Related]
35. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Suri M, Tran K, Sharma AP, Filler G, Grimmer J. Int Urol Nephrol; 2008 May; 40(3):807-10. PubMed ID: 18491215 [Abstract] [Full Text] [Related]
36. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome. Miyabe Y, Takei T, Iwabuchi Y, Moriyama T, Nitta K. Clin Exp Nephrol; 2016 Feb; 20(1):103-10. PubMed ID: 26138356 [Abstract] [Full Text] [Related]
37. Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study. Chan EY, Yu ELM, Angeletti A, Arslan Z, Basu B, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Drovandi S, Ghiggeri GM, Gipson DS, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Saini P, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yap HK, Tullus K. J Am Soc Nephrol; 2022 Jun; 33(6):1193-1207. PubMed ID: 35354600 [Abstract] [Full Text] [Related]
40. Refractory focal segmental glomerulosclerosis in the adult: complete and sustained remissions of two episodes of nephrotic syndrome after a single dose of rituximab. Marasà M, Cravedi P, Ruggiero B, Ruggenenti P. BMJ Case Rep; 2014 Aug 25; 2014():. PubMed ID: 25155494 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]